CTLA-4 Blockade and Low Dose Cyclophosphamide in Patients With Advanced Malignant Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Ipilimumab With or Without Talimogene Laherparepvec in Unresected Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Nivolumab (BMS-936558) Compared With Dacarbazine in Untreated, Unresectable, or Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE3
Treatment of Cutaneous Metastases With Diphenylcyclopropenone (DPCP)
- Status
- COMPLETED
- Phase
- PHASE1
Study to Compare the Effect of Ipilimumab Retreatment With That of Chemotherapy in Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Post-Approval Study of MelaFind
- Status
- TERMINATED
- Phase
- N/A
Natural Dendritic Cell Vaccines in Metastatic Melanoma Patients
- Status
- COMPLETED
- Phase
- PHASE1
RBL001/RBL002 Phase I Clinical Trial
- Status
- COMPLETED
- Phase
- PHASE1
Adjuvant Dabrafenib (GSK2118436) in Patients With Surgically Resected AJCC Stage IIIC Melanoma Characterized by a BRAFV600E/K Mutation
- Status
- COMPLETED
- Phase
- PHASE2
Dabrafenib With Trametinib in the Adjuvant Treatment of High-risk BRAF V600 Mutation-positive Melanoma (COMBI-AD).
- Status
- COMPLETED
- Phase
- PHASE3
Phase 2 Study of Ipilimumab Plus Dacarbazine in Japanese Patients With Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
The Value of Preoperative Dynamic Lymphscintigraphy and Ultrasoundscanning, Eventually With FNA, for Identification of Malignant Sentinel Node(s) in Patients With Melanoma
- Status
- UNKNOWN
- Phase
- NA
Phase II Safety Study of Vemurafenib Followed by Ipilimumab in Subjects With V600 BRAF Mutated Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Intratumoral Injection of Interleukin-2 and Ipilimumab in Patients With Unresectable Stages III-IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma
- Status
- COMPLETED
- Phase
- PHASE3
Pilot Study Investigating the Metabolic Activity and Transcriptional Profiling in Vivo in Tumor Biopsies in Melanoma Patients During Treatment With Pazopanib Alone and in Combination With Paclitaxel
- Status
- COMPLETED
- Phase
- PHASE2
PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Collecting Solid Tumor Tissue to Identify New Treatments
- Status
- COMPLETED
- Phase
- N/A
Study of XL888 With Vemurafenib for Patients With Unresectable BRAF Mutated Stage III/IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal Cancer
- Status
- TERMINATED
- Phase
- PHASE2